Poland Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Poland Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report “Poland Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Poland. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Polish pharmaceutical market is one of the largest emerging markets in Central and Eastern Europe (CEE), with advanced government-supported infrastructure, increased foreign business investments, improved regulatory compliance, and well-developed logistics. The Polish pharmaceutical market, based on production value, was worth $6.3 billion in 2013, which increased at a Compound Annual Growth Rate (CAGR) of 5.3% to $8.6 billion in 2019. The market value is expected to increase further and is forecast to reach $12.4 billion by 2026. In 2016, the medical devices market in Poland was worth $3.6 billion, which increased at a CAGR of 5.7% to $4.8 billion in 2021. The medical device market is expected to grow at a CAGR of 5.7% from 2022 to reach $6.6 billion in 2027. In 2021, the Polish government launched the National Health Program 2021-25, aiming to extend the lives of citizens and minimize the burden of noncommunicable illnesses by lowering the risk factors. Preventing and managing overweight, obesity, and poor mental health are among the operational goals of the program.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Poland, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Bioton, Sanofi, Novartis, GSK, and Roche.
• Profiles and SWOT analyses of the major players in the medical device market: Fresenius, Medtronic, Abbott, Stryker, and MedicALgorithmics.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Poland healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving Poland healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Poland healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership